Kunwei Shen Selected Research

Kunwei Shen Research Topics

Disease

124	Breast Neoplasms (Breast Cancer) 03/2024 - 02/2008
64	Neoplasms (Cancer) 02/2024 - 05/2002
13	Triple Negative Breast Neoplasms 12/2023 - 08/2011
7	Neutropenia 11/2022 - 05/2014
7	Neoplasm Metastasis (Metastasis) 01/2021 - 02/2008
6	Obesity 01/2022 - 05/2015
5	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2023 - 09/2016
4	Disease Progression 10/2021 - 11/2009
4	Carcinogenesis 12/2020 - 12/2012
3	Insulin Resistance 07/2023 - 01/2020
3	Febrile Neutropenia 11/2022 - 05/2014
3	Pathologic Complete Response 01/2020 - 09/2012
3	Stomatitis 11/2017 - 05/2014
2	Diarrhea 03/2024 - 11/2017
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 02/2023 - 01/2021
2	Hypertension (High Blood Pressure) 01/2021 - 01/2021
2	Overweight 01/2021 - 01/2020
1	COVID-19 11/2023
1	Residual Neoplasm 10/2023
1	Second Primary Neoplasms (Neoplasms, Second) 07/2023
1	Leukopenia 11/2022

Drug/Important Bio-Agent (IBA)

25	Estrogen ReceptorsIBA 09/2022 - 10/2009
18	human ERBB2 proteinIBA 07/2023 - 10/2009
18	Hormones (Hormone)IBA 01/2023 - 04/2009
17	Biomarkers (Surrogate Marker)IBA 01/2023 - 06/2013
16	Trastuzumab (Herceptin)FDA Link 07/2023 - 11/2009
14	Phenobarbital (Luminal)FDA Link 01/2023 - 01/2013
10	Progesterone Receptors (Progesterone Receptor)IBA 01/2022 - 10/2009
9	Tamoxifen FDA LinkGeneric 01/2022 - 01/2013
8	ErbB Receptors (EGF Receptor)IBA 01/2023 - 02/2016
7	Epidermal Growth Factor (EGF)IBA 06/2021 - 08/2012
7	Proteins (Proteins, Gene)FDA Link 01/2021 - 09/2012
6	Docetaxel (Taxotere)FDA Link 02/2023 - 12/2013
5	Messenger RNA (mRNA)IBA 08/2022 - 01/2014
5	Everolimus FDA Link 10/2021 - 10/2013
4	N-acetyltalosaminuronic acid (NAT)IBA 10/2023 - 01/2020
4	Epirubicin (Ellence)FDA LinkGeneric 02/2023 - 10/2009
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2023 - 12/2013
4	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2020
4	Insulin-Like PeptidesIBA 01/2021 - 01/2020
4	Vinorelbine (Navelbine)FDA LinkGeneric 01/2020 - 10/2009
4	Paclitaxel (Taxol)FDA LinkGeneric 11/2017 - 02/2012
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023 - 08/2011
3	Letrozole (Femara)FDA LinkGeneric 11/2022 - 10/2013
3	Selective Estrogen Receptor Modulators (SERM)IBA 10/2021 - 01/2013
3	Insulin (Novolin)FDA Link 01/2021 - 01/2020
3	Lapatinib (GW572016)FDA Link 01/2021 - 10/2010
3	C-PeptideIBA 01/2021 - 01/2020
3	Long Noncoding RNAIBA 01/2020 - 12/2017
3	Estrogens (Estrogen)FDA Link 06/2019 - 08/2012
3	Small Interfering RNA (siRNA)IBA 01/2019 - 08/2011
3	AnthracyclinesIBA 12/2016 - 12/2013
2	pertuzumabIBA 03/2024 - 01/2020
2	IsatinIBA 11/2023 - 01/2023
2	Small Cytoplasmic RNAIBA 01/2023 - 01/2020
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 08/2022 - 06/2017
2	Insulin-Like Growth Factor Binding Protein 3IBA 01/2020 - 01/2020
2	Fulvestrant (Faslodex)FDA Link 01/2020 - 08/2016
2	afimoxifene (hydroxytamoxifen)IBA 06/2019 - 01/2013
2	ParaffinIBA 06/2017 - 10/2009
2	Niclosamide FDA Link 07/2016 - 02/2016
2	Carboplatin (JM8)FDA LinkGeneric 05/2016 - 02/2012
2	benthiocarb (Bolero)IBA 07/2015 - 05/2014
2	Growth Factor ReceptorsIBA 11/2013 - 09/2012
1	Decitabine FDA Link 12/2023
1	diclofenac hydroxyethylpyrrolidine (DIEP)FDA Link 11/2023
1	indoleIBA 11/2023
1	Immunoconjugates (Immunoconjugate)IBA 10/2023
1	Triglycerides (Triacylglycerol)IBA 07/2023
1	Glucose (Dextrose)FDA LinkGeneric 07/2023
1	Metformin (Glucophage)FDA LinkGeneric 02/2023
1	Large Neutral Amino Acid-Transporter 1IBA 01/2023
1	belinostatIBA 01/2023
1	abexinostatIBA 01/2023
1	Histone Deacetylase InhibitorsIBA 01/2023
1	2- amino- 3- (4- ((5- amino- 2- phenylbenzo(d)oxazol- 7- yl)methoxy)- 3,5- dichlorophenyl)propanoic acidIBA 01/2023
1	artenimol (dihydroartemisinin)IBA 01/2023
1	tubastatin AIBA 01/2023
1	dalpiciclibIBA 01/2023
1	Glutamine (L-Glutamine)FDA Link 01/2023
1	SB939 compoundIBA 01/2023
1	artemisinin (artemisinine)IBA 01/2023
1	CarbonIBA 01/2023
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2023
1	Vorinostat FDA Link 01/2023
1	LipidsIBA 01/2023
1	PanobinostatIBA 01/2023
1	trichostatin A (A 300)IBA 01/2023
1	entinostat (MS 275)IBA 01/2023
1	romidepsin (FK228)FDA Link 01/2023
1	proxalutamideIBA 11/2022
1	palbociclibIBA 11/2022

Therapy/Procedure

35	Therapeutics 02/2024 - 11/2009
26	Drug Therapy (Chemotherapy) 01/2024 - 11/2009
18	Adjuvant Chemotherapy 10/2023 - 11/2009
18	Neoadjuvant Therapy 10/2023 - 10/2009
5	Immunotherapy 10/2023 - 09/2015
4	Radiotherapy 01/2023 - 05/2014
3	Segmental Mastectomy (Lumpectomy) 09/2022 - 01/2016
1	Mammaplasty (Breast Reconstruction) 11/2023